[The use of sympathomimetics and sympatholytics in shock].
D002746:Chlorpromazine / Q000627:therapeutic use; D004298:Dopamine / Q000627:therapeutic use; D006801:Humans; D007545:Isoproterenol / Q000627:therapeutic use; D008680:Metaraminol / Q000627:therapeutic use; D009638:Norepinephrine / Q000627:therapeutic use; D010643:Phenoxybenzamine / Q000627:therapeutic use; D010646:Phentolamine / Q000627:therapeutic use; D011433:Propranolol / Q000627:therapeutic use; D012770:Shock, Cardiogenic / Q000188:drug therapy*; D012771:Shock, Hemorrhagic / Q000188:drug therapy*; D012772:Shock, Septic / Q000188:drug therapy*
D010643:Phenoxybenzamine; D008680:Metaraminol; D011433:Propranolol; D007545:Isoproterenol; D002746:Chlorpromazine; D004298:Dopamine; D009638:Norepinephrine; D010646:Phentolamine
Sympatomimeettien ja sympatolyyttien käyttö sokissa.